https://ift.tt/s0lOVQM
from Sanofi - Aventis Groupe https://ift.tt/CLPUQ4n
via IFTTT
from health care https://ift.tt/aN92vCD
via IFTTT https://ift.tt/osI9xXV
Home
health issue
Media Update: Dupixent® (dupilumab) U.S. label updated with data further supporting use in atopic dermatitis with moderate-to-severe hand and foot involvement
- Blogger Comment
- Facebook Comment
Subscribe to:
Post Comments
(
Atom
)
0 Comments:
Post a Comment
Please ...
Don't enter span link...